Today in the Huffington Post, Public Campaign President & CEO, Nick Nyhart, discusses how last night's election result in Massachusetts was a referendum on politics in a Washington that places the interests of Wall Street titans and corporate executives ahead of the interests of ordinary Americans.

The Washington Post reports that the pharmaceutical industry is making a major lobbying push to derail a proposal that would allow the United States to import U.S.-approved medications from Canada, Europe, Australia, New Zealand and Japan, where drug prices are much cheaper because of price controls.

Politico reports that the U.S. Chamber of Commerce spent a record-breaking $34.7 million in lobbying expenses in the third quarter of 2009.

The Sunlight Foundation and the Center for Responsive Politics have teamed up on a study that shows “contribution clusters” from outside lobbyists and their health care industry clients to key members of Congress.

The Baltimore Sun has an editorial today on the battle in Congress over health care reform and the role that big money will play in the outcome. The editorial cites a recently released report by Common Cause.

CQ Politics reports on an upcoming fundraiser with Senate Finance Chairman Max Baucus (D-Mont.), who will break from crafting health care legislation to help rake in campaign cash from lobbyists and political supporters.